The Problem No One Saw Coming
A nurse adjusts an insulin drip for a critically ill patient. The dose is precise. The pump works perfectly. But the patient’s blood sugar stays high.
The issue might not be the patient or the nurse. It could be the IV tubing.
Insulin can stick to the inside of common IV bags and lines. This means less medicine reaches the patient. Blood sugar stays too high or drops too low. Both are dangerous.
This happens every day in hospitals worldwide.
A Hidden Threat in Plain Sight
Millions of ICU patients get insulin through IVs each year. Many are on ventilators, recovering from surgery, or fighting sepsis. Stable blood sugar helps them heal.
But getting it right is hard. Even small insulin losses can cause big swings in glucose.
The usual suspect? Polyvinyl chloride, or PVC. It’s the plastic in most IV bags and tubing.
PVC often contains a chemical called DEHP to make it flexible. But both PVC and DEHP have a downside. They attract insulin molecules and trap them.
Up to 70% of the first dose may never reach the bloodstream.
Doctors may not realize this is happening. They see unstable glucose and increase the dose. But the real problem is the delivery system.
Better Materials Are Already Available
For years, hospitals assumed all IV materials worked the same. But newer research shows big differences.
Polyethylene (PE), polypropylene (PP), and fluorinated ethylene propylene (FEP) absorb far less insulin.
In tests, these materials lost less than 10% of the dose. That’s a huge improvement.
Even better, they don’t contain DEHP. That matters because DEHP can leach into the bloodstream and may harm the liver, kidneys, and hormones.
Hospitals aiming for greener, safer care are switching to these alternatives.
Like a Sponge Soaking Up Water
Think of PVC tubing like a dry sponge. Pour water on it, and some flows through—but some gets trapped inside.
Insulin acts the same way. The plastic’s surface grabs the hormone before it reaches the patient.
The worst loss happens in the first minutes. That’s when the tubing is “thirsty.”
But there’s a fix: prime the line.
Flushing the tubing with 20 mL of insulin solution before starting the drip fills the “sponge.” After that, most of the insulin flows straight through.
This simple step cuts early losses by up to 90%.
A new review looked at 38 studies on insulin delivery in critical care.
It found consistent results: PVC causes the most insulin loss. Other materials do much better.
Low flow rates make the problem worse. So do lower insulin concentrations.
But priming the line helped every time.
The review also highlighted a bigger picture: patient safety and environmental health go hand in hand.
PVC and DEHP don’t just affect patients. They pollute during production and disposal.
Switching to safer materials reduces both clinical risks and environmental harm.
But there’s a catch. Hospitals don’t always use the best tubing.
Cost, supply chains, and habit keep PVC in use. Not all staff know about the adsorption problem.
And while safer materials exist, they aren’t standard everywhere.
Some alternatives, like SEBS and TPO, help but don’t solve the problem completely.
This doesn't mean this treatment is available yet.
What It Means for Patients
If you or a loved one is in the ICU on insulin, this matters.
Ask the care team what kind of IV materials they’re using.
Is the tubing PVC-free? Has it been primed?
These questions could make a real difference in blood sugar control.
But don’t demand changes on your own. This is a team decision.
Still, awareness helps. Hospitals are more likely to adopt safer practices when families and staff ask.
The Limits of the Evidence
Most studies were done in labs or with small patient groups.
Few were large clinical trials.
And while we know insulin sticks to PVC, we don’t yet have proof that switching materials directly prevents more deaths or complications.
Still, the science is strong enough to act.
The risks of unstable glucose are well known.
And the fix—using better materials and priming lines—is low-cost and safe.
The Shift Is Already Starting
Hospitals in Europe and parts of Asia are leading the change.
They’re adopting green procurement policies that phase out PVC and DEHP.
In the U.S., some health systems are following.
Device makers now offer insulin-friendly IV sets.
More research is coming. But waiting for perfect data could cost lives.
For now, the smart move is clear: use better materials, prime the lines, and protect patients from avoidable harm.
Change takes time. But in the ICU, every drop of insulin counts.